Phase II trials
Clinical Trials Watch
This section contains information about clinical trials that are:
- Currently recruiting participants
- Conducted at least in one European country
- In phase II (in these trials the drug / treatment is tested in groups involving up to several hundred participants with the disease/condition. These trials are conducted to explore the therapeutic efficacy of the drug / treatment in participants.)
How many Phase II trials are reported in the CTW?
The CTW reports currently 8 ongoing Phase II clinical trials recruiting participants in Europe. These trials are listened in the table below:
| Study | Study sponsor | Name of the drug | Condition |
| ACI-35-1802 | AC Immune | ACI-35.030 or JACI-35.054 | Early Alzheimer's disease |
| Janssen | JNJ-63733657 | Early Alzheimer's disease |
|
| Brainshuttle AD | Hoffmann-La Roche | RO7126209 | Prodromal or mild to moderate Alzheimer's disease |
| DESPIAD | University College London | CPHPC | Mild Alzheimer's disease |
| INFRONT2 | Alector | AL001 | Frontotemporal dementia |
| INVOKE-2 | Alector | AL002 | Early Alzheimer's disease |
| TRAILBLAZER-ALZ 2 | Eli Lilly | Donanemab | Early Alzheimer's disease |
| VIVIAD | Vivoryon Therapeutics AG | PQ912 | Mild cognitive impairment and mild dementia due to Alzheimer 's Disease |
Last Updated: Monday 18 October 2021
